Search

Your search keyword '"Bertelli, D."' showing total 161 results

Search Constraints

Start Over You searched for: Author "Bertelli, D." Remove constraint Author: "Bertelli, D."
161 results on '"Bertelli, D."'

Search Results

1. La risonanza magnetica nella scienza degli alimenti. Con e-book

3. Computer assisted planning for total knee arthroplasty

4. A community-built calibration system: The case study of quantification of metabolites in grape juice by qNMR spectroscopy

10. Incidence of Malignancies in HIV‐Infected Patients and Prognostic Role of Current CD4 Cell Count: Evidence from a Large Italian Cohort Study

12. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

14. Polyphenols, anthocyanins, ascorbic acid, and radical scavenging activity of Rubus, Ribes, and Aronia

15. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

16. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

17. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

18. Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008

19. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

20. Performance Assessment in Fingerprinting and Multi Component Quantitative NMR Analyses

21. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

22. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts

23. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

24. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

25. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count

26. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure

27. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

28. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study

29. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

30. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

31. Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

32. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

33. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

34. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis

35. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina

36. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

37. Genetic polymorphisms differently influencing the emergence of atrophy and fataccumulation in HIV-related lipodystrophy

38. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

39. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

40. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

41. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

42. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

43. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study

44. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads

45. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

46. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy

50. Partnership of HIV-Infected Women and Health Status

Catalog

Books, media, physical & digital resources